Loading clinical trials...
Loading clinical trials...
Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI) in Non-Cirrhotic Patients - A Double Blind International Multicenter Study
The purpose of this multicenter study is to evaluate the agreement among expert radiologists in interpreting magnetic resonance images (MRI) assessing common primary liver tumours in non-cirrhotic patients.
Magnetic Resonance Imaging (MRI) is currently the method of choice for non-invasive diagnosis of primary liver tumors. However, differentiation of hepatocellular carcinoma (HCC) from adenoma and focal nodular hyperplasia (FNH) remains challenging, particularly in non-cirrhotic patients.
Age
18 - 90 years
Sex
ALL
Healthy Volunteers
No
Harvard Medical School, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
St. Louis University, Liver Center
St Louis, Missouri, United States
University Hospital Strasbourg
Strasbourg, Cedex, France
University Hospital Essen
Essen, Germany
Auckland City Hospital
Auckland, Auckland, New Zealand
University Hospital Zurich, Department of Interventional and Diagnostic Radiology
Zurich, Canton of Zurich, Switzerland
University Hospital Zurich, Department of Visceral and Transplant Surgery, Swiss Hepato-Pancreato-Biliary (HPB) Center
Zurich, Canton of Zurich, Switzerland
The Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom
University College London Hospitals NHS Foundation Trust
London, United Kingdom
Imperial College, Hammersmith Hospital
London, United Kingdom
Start Date
October 1, 2010
Primary Completion Date
May 1, 2012
Completion Date
May 1, 2012
Last Updated
May 28, 2012
108
ACTUAL participants
Non-invasive Magnetic Resonance Imaging (MRI)
OTHER
Liver resection
PROCEDURE
Histopathology diagnosis of resected liver specimen
OTHER
Lead Sponsor
University of Zurich
Collaborators
NCT07213804
NCT07169851
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions